Vitestro will be the first to bring autonomous blood drawing technology to European hospitals. Blood drawing, performed billions of times per year worldwide, is key to clinical diagnosis. Given a growing population and shortages of healthcare personnel, there is a clear need for a future-proof system to keep up with demand for diagnostics.
$21M sweet spot round size
2017
$21M
from 3 investors over 1 rounds
Vitestro raised $21M on May 30, 2024
Investors: NYBC Ventures, Sonder Capital and + 2 Other investors